FDA Recalls Testosterone Cypionate and Anastrazole Injection Due to Sterility Concerns
The Compounding Pharmacy of America is recalling Testosterone Cypionate and Anastrazole Injection because FDA inspections found GMP violations that may affect sterility.
- Product
- Testosterone Cypionate 200 mg/ml Anastrazole 0.5 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
- Category
- Drug
- Distribution
- Distributed nationwide